Tom Wilemon Archive

The study team included, from left, Douglas Johnson, MD, Dan Roden, MD, Javid Moslehi, MD, Joe-Elie Salem, MD, PhD, and Ali Manouchehri, MD.
September 25, 2019

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.

By Tom Wilemon
September 18, 2019

Jackson named to new VICC advanced practice role

Heather Jackson, MSN, RN, APRN, has been promoted to administrative director of Advanced Practice for Vanderbilt-Ingram Cancer Center.

By Tom Wilemon
DNA sequence
September 5, 2019

Study backs genetic testing for all metastatic breast cancer patients

By Tom Wilemon
September 4, 2019

Fashion event to help support ovarian cancer research

Vanderbilt Health physicians will be among the runway models during the 7th Annual T.J. Martell Foundation Chic Awearness on Sept. 23.

By Tom Wilemon
August 26, 2019

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

By Tom Wilemon
August 22, 2019

Grant strengthens breast cancer research efforts

Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.

By Tom Wilemon